9 Meters Biopharma Inc (NMTR)

INFORMATION TECHNOLOGY: COMPUTERS & PERIPHERALS
SIC: PHARMACEUTICAL PREPARATIONS

8480 HONEYCUTT ROAD RALEIGH, NC 27615

9 Meters Biopharma, Inc. ('the Company') is a rare and unmet needs-focused gastroenterology company. The Company is advancing NM-002, a proprietary long-acting GLP-1 agonist into a Phase 2 trial for short bowel syndrome (SBS), a rare, orphan disease, as well as larazotide, a Phase 3 tight junction regulator being evaluated for patient-reported symptom improvement in non-responsive celiac disease.

Data as of 2021-08-02 08:51:53 -0400
Market Cap271.482 Million Shares Outstanding251.372 Million Avg 30-day Volume6.205 Million
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.45214 52-week High/Low2.26 / 0.4512 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from NMTR instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 90 57 57.89% 34 (2.0%) 23 (1.33%) 47.83%
13F shares: 75.855 Million 60.718 Million 24.93% 56.428 Million 44.399 Million 27.09%
% Ownership 35.1064 29.8514 17.6% 26.1156 21.8282 19.64%
New Positions: 44 24 83.33% 16 13 23.08%
Increased Positions 23 14 64.29% 11 3 266.67%
Closed Positions 11 8 37.5% 5 3 66.67%
Reduced Positions 11 5 120.0% 4 3 33.33%
Total Calls 2.226 Million 828.594 Thousand 168.63% 116.7 Thousand 139.7 Thousand -16.46%
Total Puts 415.824 Thousand 68.524 Thousand 506.83% 63.297 Thousand 52.713 Thousand 20.08%
PUT/CALL Ratio 0.19 0.08 137.5% 0.54 0.38 42.11%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding NMTR (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NMTR BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

17.2 Million total shares from 3 transactions

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

ORBIMED ISRAEL GP LTD.

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP

  • 10% Owner
8,597,918 2021-06-23 3

JOHNSON LORIN K

  • Director
90,000 2021-06-22 1

SIRGO MARK A

  • Director
90,000 2021-06-22 6

CONSTANTINO MICHAEL T.

  • Director
90,000 2021-06-22 2

SITAR EDWARD J CHIEF FINANCIAL OFFICER

  • Officer
179,338 2021-04-05 3

TEMPERATO JOHN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
1,077,522 2021-04-05 7

RICE YEHUDA MICHAEL

  • Director
0 2021-02-26 2

DARVISH NISSIM

  • Director
  • 10% Owner
25,716,755 2020-10-30 1

LAUMAS SANDEEP

  • Director
0 2020-07-06 0

MADAN JAY P. PRESIDENT

  • Officer
  • Director
No longer subject to file 2020-04-24 0

MAIDA ANTHONY E III

  • Director
No longer subject to file 2020-04-24 0

PROUJANSKY ROY

  • Director
0 2020-04-24 0

RAMASASTRY SAIRA

  • Director
No longer subject to file 2020-04-24 0

PRIOR CHRISTOPHER P. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
7,009 2018-11-29 0

ALMENOFF JUNE SHERIE COO AND CHIEF MEDICAL OFFICER

  • Officer
2,800 2018-08-24 0

KAZANCHYAN ANNA

  • Director
0 2018-01-29 0

SEA ISLAND PARTNERSHIP LLC

  • 10% Owner
2,892,298 2018-01-29 0

MOONSTAR FAMILY PARTNERSHIP LLC

  • 10% Owner
2,688,217 2018-01-29 0

OLERT DAVID LEWIS FORMER CFO

  • Officer
70,000 2018-01-25 0

CLARK JONATHAN P FORMER INTERIM PRES & DIRECTOR

  • Officer
  • Director
285,000 2018-01-25 0

BARRE STEVEN C

  • Director
50,000 2017-11-09 0

MINER CHRISTOPHER MICHAEL

  • Director
35,000 2017-05-31 0

MACHINIST ROBERT

  • Director
35,000 2017-05-31 0

BROWNSELL STEPHEN R EVP

  • Officer
135,000 2017-02-01 0

MATEJKA MARC S VP - OPERATIONS

  • Officer
40,000 2017-01-24 0

CLARKE DAVID H FORMER CEO AND DIRECTOR

  • Officer
  • Director
3,136,900 2016-07-13 0

ORBAN JONATHAN S

  • Director
0 2016-07-07 0

TANDON VIVEK EVP - OPERATIONS

  • Officer
0 2016-07-07 0

TANDON JAWAHAR CHAIRMAN OF THE BOARD

  • Officer
  • Director
0 2016-07-07 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

ORBIMED ISRAEL GP LTD. - > 10% Owner see footnotes

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP - > 10% Owner see footnotes

2021-06-25 19:08:22 -0400 2021-06-25 S 15,989,876 $1.21 d 8,565,974 indirect -3.5088 -6.1404 0.0 1 -6.1404 6

ORBIMED ISRAEL GP LTD. - > 10% Owner see footnotes

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP - > 10% Owner see footnotes

2021-06-25 19:08:22 -0400 2021-06-24 S 319,255 $1.38 d 24,555,850 indirect -3.5088 -6.1404 0.0 1 -6.1404 6

ORBIMED ISRAEL GP LTD. - > 10% Owner see footnotes

ORBIMED ISRAEL BIOFUND GP LIMITED PARTNERSHIP - > 10% Owner see footnotes

2021-06-25 19:08:22 -0400 2021-06-23 S 841,650 $1.36 d 24,875,105 indirect -3.5088 -6.1404 0.0 1 -6.1404 6

SIRGO MARK A - Director

2021-06-23 16:15:55 -0400 2021-06-22 A 90,000 a 90,000 direct

CONSTANTINO MICHAEL T. - Director

2021-06-23 16:15:07 -0400 2021-06-22 A 90,000 a 90,000 direct

JOHNSON LORIN K - Director

2021-06-23 16:15:31 -0400 2021-06-22 A 90,000 a 90,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
9 METERS BIOPHARMA INC NMTR 2021-08-05 22:15:04 UTC -1.1276 1.2076 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 21:45:03 UTC -1.1202 1.2002 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 21:15:03 UTC -1.1202 1.2002 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 20:45:03 UTC -1.1017 1.1817 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 20:15:04 UTC -1.1017 1.1817 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 19:45:04 UTC -1.1017 1.1817 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 19:15:03 UTC -1.1017 1.1817 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 18:45:03 UTC -1.0841 1.1641 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 18:15:03 UTC -1.0841 1.1641 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 17:45:03 UTC -1.0841 1.1641 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 17:15:03 UTC -1.0841 1.1641 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 16:45:02 UTC -1.0559 1.1359 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 16:15:03 UTC -1.0559 1.1359 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 15:45:03 UTC -1.0559 1.1359 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 15:15:02 UTC -1.0559 1.1359 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 14:45:02 UTC -0.9992 1.0792 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 14:15:04 UTC -0.9992 1.0792 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 13:45:04 UTC -0.9992 1.0792 4400000
9 METERS BIOPHARMA INC NMTR 2021-08-05 13:15:03 UTC -0.9992 1.0792 4300000
9 METERS BIOPHARMA INC NMTR 2021-08-05 12:45:03 UTC -0.9992 1.0792 4300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments